<DOC>
	<DOC>NCT02188173</DOC>
	<brief_summary>This is a study of OZURDEX® use in clinical practice in patients with diabetic macular edema (DME).</brief_summary>
	<brief_title>An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Diagnosis of DME in at least one eye treated OZURDEX® per clinical practice</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>